Archive for August, 2006



Medical News Today - The March of Dimes today urged Food and Drug Administration officials to promptly approve a commercial progesterone therapy that appears to prevent some premature births. Dr. Nancy Green, March of Dimes medical director, testified before the FDA …

September is National Food Safety Education Month, created by the National Restaurant Association Educational Foundation’s International Food Safety Council to heighten awareness of the importance of food safety education throughout the restaurant and foodservice industry.

A Canadian pharmacy group Thursday blasted the U.S. Food and Drug Administration for its warning this week on drugs sold on some Canada Web sites.

Aug. 31 (Bloomberg) — Sanofi-Aventis SA said the U.S. Food and Drug Administration rejected its Multaq treatment for irregular heartbeat because the agency wanted more data.

Sanofi Says US Rejects Drug for Irregular Heartbeat (Update3)Bloomberg - 52 minutes ago… 31 (Bloomberg) — Sanofi-Aventis SA said the US Food and Drug Administration rejected its Multaq treatment for irregular heartbeat because the agency wanted…

FDA reclassifies morning-after pill

Date: 8/31/06 Section: News Media Credit: Gavin McChesney Plan B, an emergency contraceptive currently available only by prescription, is expected to be released soon as an over-the-counter drug.

Syracuse Post-Standard - Food and Drug Administration. However, based on information from the FDA and the New York State Department of Health, Kinney officials said the level of bromate discovered in the affected bottled water did not pose a health risk in humans. “We want to …

Girls under 18 ‘left behind’People’s Weekly World - 13 hours agoBittersweet. It’sa good word to describe the anticipated US Food and Drug Administration’s recent approval of the controversial contraceptive pill, Plan B. … FDA Safety Cha…

French pharmaceutical company Sanofi-Aventis SA said Thursday it received a non-approvable letter from the U.S. Food and Drug Administration for dronedarone, a heart drug known by its trade name Multaq.

Health News - Canada East

Health NewsCanada East, Canada - 1 hour ago… WINNIPEG (CP) - The US Food and Drug Administration blindsided Canada's online pharmacists Wednesday with a report that found fake versions of Lipitor and … Health News Canada EastHealth N…

WGRZ TV - WASHINGTON — The Food and Drug Administration says testing has revealed fake versions of Lipitor and other widely used prescription drugs have been sold through Web sites linked to a Canadian pharmacy. The F-D-A says consumers who bought drugs …

French pharmaceutical company Sanofi-Aventis SA said Thursday it received a letter of non-approval from the U.S. Food and Drug Administration for dronedarone, a heart drug known by its trade name Multaq.

MSN MoneyCentral - PARIS (AP) - French pharmaceutical company Sanofi-Aventis SA said Thursday it received a non-approvable letter from the U.S. Food and Drug Administration for dronedarone, a heart drug known by its trade name Multaq. Sanofi said it expects to reapply …

National Cancer Institute (NCI) “New Method of Gene Therapy Alters Immune Cells for Treatment of Advanced Melanoma; Technique May Also Apply to Other Common Cancers”, Thursday, August 31, 2006

The Food and Drug Administration has posted a warning on its Web site advising consumers not to order prescriptions online from Web sites that offer drugs through the Mediplan Prescription Plus Pharmacy or Mediplan Global Health in Manitoba, Canada. The FDA said there are reports that these companies are selling counterfeit versions of prescription drug to Americans, and the agency is advising




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for August, 2006.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories